Portfolio Lab

Imax Corp

  • Stock
  • Ticker IMAX
  • ISIN CA45245E1097
  • NYSE
  • US listing in dollars

Technology · Electronics and instruments · Other countries

$46.13 −0.11%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Imax Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

IMAXGlobal equities (VT)

$10,000 grew to $13,256. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −79.4% in 03/2020, measured from the peak in 11/2016. It took 108 months to get back to the old peak.

1-year return
+30.3%
5-year return p.a.
+20.3%
10-year return p.a.
+2.9%
Volatility p.a.
43.3%
Largest decline
−79.4%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue93879210712581103175
Gross profit48535467724663126
Operating income9.51714292410.02175
EBITDA26323045402536102
Net income5.32.311210.64.215114
Earnings per share0.090.040.200.370.010.070.271.96
Balance sheet
Total assets8308488698908948939181,030
Liabilities452464464453466465467440
Equity299300320350338335356492
Cash10197109143151146160208
Cash flow
Operating cash flow117.02368294.03286
Capital expenditure-4.6-1.6-2.4-2.7-1.4-2.10.0-1.9
Free cash flow6.95.32165281.93284

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2024 at +70.4%, weakest 2017 at −26.3%. 4 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$1.96
23 Jul 2026$0.27
30 Apr 2026$0.07
25 Feb 2026$0.01
23 Oct 2025$0.37
24 Jul 2025$0.20
23 Apr 2025$0.04
19 Feb 2025$0.09
30 Oct 2024$0.26
25 Jul 2024$0.07
25 Apr 2024$0.06
27 Feb 2024$0.05

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€2.3bn
Market cap in trading currency
$2.55bn
Enterprise value
$2.34bn
P/E
20.0
P/S
5.26
P/B
5.18
EV/Sales
4.83
EV/EBITDA
11.5
Earnings yield
5.0%
FCF yield
5.7%

Results (last four quarters)

Revenue
$484m
Gross profit
$307m
EBITDA
$203m
Net income
$134m
Earnings per share
$2.31
Revenue per share
$8.77
Revenue growth
+63.7%
Earnings growth
+450.9%

Profitability

Gross margin
63.5%
Operating margin
26.8%
Net margin
27.7%
Return on equity
31.9%
Return on assets
13.0%

Balance sheet and cash flow

Cash
$208m
Cash per share
$3.77
Financial debt
–
Debt/equity %
–
Current ratio
–
Book value per share
$8.90
Operating cash flow
$151m
Free cash flow
$146m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
55.2m
Volume
1.30m
Avg. volume 3 months
1.00m
Relative volume
1.3

Price and technicals

Price
$46.13
1 day
−0.1%
52-week high
$56.33
52-week low
$33.09
Distance to 52-week high
−18.1%
Distance to 52-week low
+39.4%
Distance to 50-day line
−10.1%
Distance to 200-day line
+5.3%
RSI (14)
34
Volatility 1M
37.2%

Performance

1 week
−4.5%
1 month
−11.8%
3 months
−15.8%
6 months
+17.9%
YTD
+24.8%
1 year
+26.6%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has IMAX performed since 11/2016?

$10,000 grew to $13,256 by 20 Nov 2026, which is +2.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is IMAX?

Volatility was 43.3% per year, measured on monthly returns. The largest decline from a peak was −79.4%, with the low in 03/2020.

How does IMAX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, IMAX returned +2.9% at 43.3%. The correlation of monthly returns was 0.43; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Imax Corp (IMAX): Return and risk | Portfolio Lab